Nuzenio

Developed Adc Drug

Developed Adc Drug news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 9 publisher sources 100/100 entity strength

Latest news

LigaChem Bio Gains Sole Development Rights to Co-Developed ADC Drug - Seoul Economic DailySeoul Economic Daily · Fri, 07 Aug 2026 04:55:57 GMT Osteosarcoma ADC breakthrough sparks race as SOT106 readies trials and deals - CHOSUNBIZ - ChosunbizChosunbiz · Thu, 06 Aug 2026 21:01:00 GMT Pathos Picks Up Two Cancer Drugs Poised for Clinical Development With AI Agents - MedCity NewsMedCity News · Tue, 04 Aug 2026 20:22:15 GMT Pathos AI Enters Global Licensing Agreement with Alphamab Oncology on JSKN016, a First-in-Class TROP2/HER3 Bispecific ADC - businesswire.combusinesswire.com · Tue, 04 Aug 2026 00:00:00 GMT Fujifilm and Taiho Pharmaceutical Enter into Strategic Partnership for Development of Next-Generation Antibody-Drug Conjugate (ADC) Manufacturing Technologies - markets.businessinsider.commarkets.businessinsider.com · Mon, 03 Aug 2026 20:38:41 GMT Understanding the toxicology endpoints that matter in ADC development - Drug Target ReviewDrug Target Review · Mon, 03 Aug 2026 06:23:53 GMT Before the Hype: Five Early-Stage ADC Startups to Watch - Inside Precision MedicineInside Precision Medicine · Sat, 01 Aug 2026 10:40:57 GMT Lonza and Engitix partner to develop next-generation antibody-drug conjugates - PharmafilePharmafile · Tue, 28 Jul 2026 07:00:00 GMT

Timeline

Fri, 07 Aug 2026 04:55:57 GMTLigaChem Bio Gains Sole Development Rights to Co-Developed ADC Drug - Seoul Economic Daily

Thu, 06 Aug 2026 21:01:00 GMTOsteosarcoma ADC breakthrough sparks race as SOT106 readies trials and deals - CHOSUNBIZ - Chosunbiz

Tue, 04 Aug 2026 20:22:15 GMTPathos Picks Up Two Cancer Drugs Poised for Clinical Development With AI Agents - MedCity News

Tue, 04 Aug 2026 00:00:00 GMTPathos AI Enters Global Licensing Agreement with Alphamab Oncology on JSKN016, a First-in-Class TROP2/HER3 Bispecific ADC - businesswire.com

Mon, 03 Aug 2026 20:38:41 GMTFujifilm and Taiho Pharmaceutical Enter into Strategic Partnership for Development of Next-Generation Antibody-Drug Conjugate (ADC) Manufacturing Technologies - markets.businessinsider.com

Mon, 03 Aug 2026 06:23:53 GMTUnderstanding the toxicology endpoints that matter in ADC development - Drug Target Review

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Development4 live mentions ADC4 live mentions Seoul Economic Daily3 live mentions Drug Target Review3 live mentions LigaChem Bio Gains2 live mentions Sole Development Rights2 live mentions Clinical Development With2 live mentions Pathos AI Enters2 live mentions Global Licensing Agreement2 live mentions Alphamab Oncology2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Developed Adc Drug.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.